Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
← catalyst calendarNCT06561048 · readout ≤ 468 d
Sponsored by Corvus Pharmaceuticals, Inc. (industry) · CRVS — their whole pipeline →.
Phase
Phase 3
Status
Recruiting
Study type
Interventional
Design
Randomized · None · Treatment
Enrollment
150estimated
Sites
34
Countries
Australia, Canada, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-10-02 | actual | When the study began enrolling |
| Primary completion | Nov 2027 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | Dec 2028 | estimated | The whole study's end, after follow-up |
| First posted | 2024-08-19 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-04-08 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Angioimmunoblastic T-cell Lymphoma
- Follicular T-Cell Lymphoma
- Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
- Systemic Anaplastic Large Cell Lymphoma
- Lymphoma, T-Cell, Peripheral
- Lymphoma, T-Cell
Interventions
- Drug: Soquelitinib — also filed as CPI-818
- Drug: Belinostat — also filed as Beleodaq®
- Drug: Pralatrexate — also filed as Folotyn®
Primary outcome
what the primary-completion date above is the date OFProgression-free survival
measured Up to 4 years post study treatment initiation
Permalink · CRVS's whole pipeline · Catalyst calendar · Every registered study · What changed